Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 4,052 | 3,877 | 2,335 | 3,523 | 1,178 |
| Cost of Goods | 576 | 2,115 | 1,050 | 597 | N/A |
| Gross Profit | 3,476 | 1,762 | 1,284 | 2,926 | N/A |
| Operating Expenses | 12,494 | 17,380 | 37,309 | 27,079 | 31,467 |
| Operating Income | -9,017 | -15,619 | -36,024 | -24,153 | -30,289 |
| Interest Expense | 1,029 | 741 | N/A | N/A | N/A |
| Other Income | 10,046 | 16,360 | 2,202 | 1,300 | 1,215 |
| Pre-tax Income | N/A | N/A | -33,822 | -22,853 | -29,074 |
| Income Tax | N/A | N/A | N/A | -1 | 1 |
| Net Income Continuous | -7,598 | -15,882 | -33,822 | -22,853 | -29,075 |
| Net Income | $-7,598 | $-15,882 | $-33,822 | $-22,853 | $-29,075 |
| EPS Basic Total Ops | -0.07 | -0.15 | -0.32 | -0.27 | -0.37 |
| EPS Basic Continuous Ops | -0.07 | -0.15 | -0.32 | -0.27 | -0.37 |
| EPS Diluted Total Ops | -0.07 | -0.15 | -0.32 | -0.27 | -0.37 |
| EPS Diluted Continuous Ops | -0.07 | -0.15 | -0.32 | -0.27 | -0.37 |
| EBITDA(a) | $-7,742 | $-14,217 | $-34,261 | $-22,602 | $-28,153 |